AOD-9604 and BPC-157 in Combination Research AOD-9604 and BPC-157 are frequently mentioned together in peptide research discussions because theyre studied in adjacent but distinct areas AOD-9604 in fat metabolism, BPC-157 in tissue repair and gastrointestinal research rather than because of any overlapping mechanism
Ideally, youd want labs done at the beginning and again with each dose increase, or at least every 36 months, to make sure the medication is working safely and not causing unwanted side effects
Manage stress through evidence-based techniques to support optimal healing hormonal environment
In the presence of neurological symptoms, following daily treatment, injections up to weekly or biweekly are indicated for six months before initiating monthly IM injections
Avoid repeated freeze-thaw cycles in the reconstituted form every freeze-thaw cycle damages peptide structure and reduces potency
For those considering AOD-9604 , realistic expectations and patience are essential